| Robert Denholm, CRNA | |
|
1230 Northway Dr., Anchorage, AK 99508 | |
| (907) 550-6100 | |
| (402) 343-8765 |
| Full Name | Robert Denholm |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1230 Northway Dr., Anchorage, Alaska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710091533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 100700 (Nebraska) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | NURA442 (Alaska) | Primary |
| Entity Name | Chugach Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093712358 PECOS PAC ID: 2961465653 Enrollment ID: O20041109001035 |
News Archive
A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at the University of Strathclyde.
The study found that states that expanded Medicaid and set up their own exchanges experienced greater declines in the rate of uninsurance than those that didn't. Nationwide, the percentage of uninsured Americans dropped from 18 percent in September 2013, to 13.4 percent in June 2014, according to the survey.
Cancer Research Technology announced today that it has entered into a license agreement granting Genentech, Inc. exclusive worldwide rights to its patent portfolio covering an oncology target discovered in the Molecular Oncology Laboratory (Oxford) of Cancer Research UK.
Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care within 48 hours after they get to the hospital, according to a new study published in the May 24, 2017, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.
Pfizer Inc. today announced that the randomized Phase 2 trial [PALOMA-1] of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for the combination of palbociclib and letrozole compared with letrozole alone in post-menopausal women with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or newly diagnosed metastatic breast cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Denholm, CRNA Alaska Surgery Center, 1230 Northway Drive, Anchorage, AK 99508 Ph: (907) 550-6100 | Robert Denholm, CRNA 1230 Northway Dr., Anchorage, AK 99508 Ph: (907) 550-6100 |
News Archive
A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at the University of Strathclyde.
The study found that states that expanded Medicaid and set up their own exchanges experienced greater declines in the rate of uninsurance than those that didn't. Nationwide, the percentage of uninsured Americans dropped from 18 percent in September 2013, to 13.4 percent in June 2014, according to the survey.
Cancer Research Technology announced today that it has entered into a license agreement granting Genentech, Inc. exclusive worldwide rights to its patent portfolio covering an oncology target discovered in the Molecular Oncology Laboratory (Oxford) of Cancer Research UK.
Hospitals vary widely in how often they transition people with strokes from active treatment to comfort or hospice care within 48 hours after they get to the hospital, according to a new study published in the May 24, 2017, online issue of Neurology Clinical Practice, an official journal of the American Academy of Neurology.
Pfizer Inc. today announced that the randomized Phase 2 trial [PALOMA-1] of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for the combination of palbociclib and letrozole compared with letrozole alone in post-menopausal women with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or newly diagnosed metastatic breast cancer.
› Verified 2 days ago
Mrs. Jennifer Rae Ambrose, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4100 Lake Otis Pkwy, Suite 222, Anchorage, AK 99508 Phone: 612-269-1918 | |
Waldron Upham, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4100 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-550-6110 | |
Tara Mccutcheon, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2801 Debarr Rd, Anchorage, AK 99508 Phone: 801-915-1873 | |
Bucky M Frost, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508 Phone: 907-729-3971 Fax: 907-729-1542 | |
Suzanne C Firth, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 5955 Zeamer Avenue, Anchorage, AK 99506 Phone: 907-580-1815 | |
Mrs. Alicia Marie Ferguson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 611 Clipper Ship Ct, Anchorage, AK 99515 Phone: 907-306-1274 | |
Angela Malcom, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4100 Lake Otis Pkwy, Anchorage, AK 99508 Phone: 907-550-6110 |